
SIOX
Healthcare · Biotechnology · $35.4M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2022
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 11, 2024 | Time not confirmed | 0.07 | 0.00 | -100.0% |
| Nov 3, 2023 | Before the open | -0.01 | 0.00 | +100.0% |
| Aug 10, 2023 | Time not confirmed | -0.06 | 0.00 | +100.0% |
| Jun 13, 2023 | Time not confirmed | -0.14 | 0.00 | +100.0% |
| Feb 14, 2023 | Before the open | -0.17 | -0.05 | +67.5% |
| Nov 10, 2022 | Before the open | -0.17 | -0.04 | +75.8% |
| Aug 11, 2022 | Before the open | -0.16 | -0.11 | +33.0% |
| Jun 14, 2022 | Before the open | -0.20 | -0.18 | +10.0% |
| Feb 11, 2022 | Before the open | -0.22 | -0.35 | -59.1% |
| Nov 12, 2021 | Before the open | -0.17 | -0.29 | -70.6% |
| Aug 12, 2021 | Before the open | -0.18 | -0.16 | +11.1% |
| Jun 9, 2021 | Before the open | -0.17 | -0.05 | +70.6% |
| Feb 9, 2021 | Before the open | -0.29 |
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates,…
| -0.20 |
| +31.0% |
| Nov 13, 2020 | Before the open | -0.29 | -0.21 | +27.6% |
| Aug 11, 2020 | Before the open | -0.44 | -0.20 | +54.5% |
| Jun 10, 2020 | Before the open | -0.58 | -0.54 | +6.9% |
| Feb 10, 2020 | Before the open | -0.67 | -0.62 | +7.5% |
| Nov 8, 2019 | Before the open | -1.09 | -0.61 | +44.0% |
| Aug 9, 2019 | Before the open | -0.91 | -1.23 | -35.2% |
| Jun 11, 2019 | After the close | -1.70 | -0.45 | +73.5% |
| Feb 7, 2019 | After the close | -2.08 | -2.16 | -3.8% |
| Nov 7, 2018 | After the close | -2.92 | -2.24 | +23.3% |
| Aug 7, 2018 | After the close | -1.47 | -3.84 | -161.2% |
| Jun 11, 2018 | Before the open | -2.91 | -1.84 | +36.8% |
| Feb 9, 2018 | After the close | -3.97 | -4.32 | -8.8% |